Thu, May 23, 2019
Wed, May 22, 2019
Tue, May 21, 2019
Mon, May 20, 2019
Fri, May 17, 2019
Thu, May 16, 2019
Wed, May 15, 2019
Tue, May 14, 2019
Mon, May 13, 2019
Fri, May 10, 2019
Thu, May 9, 2019
Wed, May 8, 2019
Tue, May 7, 2019
Mon, May 6, 2019
Fri, May 3, 2019
Thu, May 2, 2019
Wed, May 1, 2019
Tue, April 30, 2019
Mon, April 29, 2019
Fri, April 26, 2019

Brian Abrahams Maintained (SRPT) at Buy with Decreased Target to $188 on, May 9th, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-188-on-may-9th-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Brian Abrahams of RBC Capital, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Decreased Target from $191 to $188 on, May 9th, 2019.

Brian has made no other calls on SRPT in the last 4 months.



There are 4 other peers that have a rating on SRPT. Out of the 4 peers that are also analyzing SRPT, 0 agree with Brian's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Brian


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $169 on, Monday, March 4th, 2019
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Increased Target to $201 on, Friday, March 1st, 2019
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $231 on, Thursday, February 28th, 2019
  • Christopher Marai of "Nomura" Maintained at Strong Buy with Increased Target to $230 on, Thursday, February 28th, 2019

Publication Contributing Sources